The e-commerce giant has risen every trading day so far this year. For two analysts, the streak isn't over yet. » Read More
By: Jeff Cox
A good start to the year is only going to get better for J.P. Morgan Chase, according to veteran banking analyst Dick Bove. » Read More
By: Rick Levinson
Don't mistake affability for financial savvy — the investment seller may be a con man. » Read More
Komal Sri-Kumar sees a continued short-term rise in the stock market with "a much sharper fall at some point in time." » Read More
Instinent says Qualcomm needs approval for its NXP Semiconductors merger from U.S., China, Japan, South Korea, Taiwan and the EU.
Some of the names on the move ahead of the open.
A daily look at the morning's key financial stories.
The biggest driver of the markets will be just how well the new administration implements its plans, some analysts say.
Stocks may have struggled in the past two weeks, but one top strategist predicts the rally will regain momentum.
T-Mobile could be involved in tie-up with Sprint, or be acquired by a cable company, JP Morgan said
Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns.
The Apple chip provider reported first quarter earnings of $1.61 per share on revenues of $914 million.
Former materials and engineering heavyweight splits earnings into Arconic and Alcoa.
Trump offered precious little about the issues that would matter most to earnings: tax cuts and infrastructure spending.
Forty-two firms have posted quarterly results as of Wednesday, and FactSet said 11 discussed tax policy in their conference calls.
"Ultimately something is going to happen," one FX strategist said. "But probably it's not going to be as extreme as some people had assumed."
Following a morning rally before Donald Trump's inauguration, stocks waffled.
The streak could signal increased volatility to come, according to some market strategists.
TransDigm "acquires airplane parts companies (over 50 in total), fires employees, and egregiously raises prices," Citron says in its report.
The JPMorgan Chase CEO said the 45th president's enthusiasm for economic development is encouraging.
The lung cancer treatment is still expected to receive approval in the second half of 2018.
Treasurys should struggle as investors dump the safe haven during this typically hopeful time of change, if history repeats itself.
History suggests the stock market will give Trump a warm welcome to the presidency, but it will be up to him how long the honeymoon lasts.
NAFTA, TPP and healthcare are among the topics that could move markets, Cramer says.
Get the best of CNBC in your inbox